The impact of hepatitis C virus donor and recipient status on long-term kidney transplant outcomes: University of Wisconsin experience

Clinical Transplantation

Volumn 26, Issue 5, 2012, Pages 684-693

  Singh, Neeraj ^a,b   Neidlinger, Nikole ^a   Djamali, Arjang ^a   Leverson, Glen ^a   Voss, Barbara ^a   Sollinger, Hans W ^a   Pirsch, John D ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Hepatitis C positive donors; Hepatitis C positive recipients; Hepatitis C virus; Kidney transplantation; Transplant outcomes

Indexed keywords

ALEMTUZUMAB; AZATHIOPRINE; BASILIXIMAB; DACLIZUMAB; DEXAMETHASONE; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PREDNISONE; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; CHRONIC ALLOGRAFT NEPHROPATHY; DRUG DOSE REDUCTION; FEMALE; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT SURVIVAL; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; KIDNEY DONOR; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SURVIVAL RATE;

ADULT; AGED; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HEPACIVIRUS; HEPATITIS C; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PROGNOSIS; RECURRENCE; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS; TISSUE DONORS; UNIVERSITIES;

EID: 84867640563     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2011.01583.x     Document Type: Article

References (41)

1. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989: 244: 359.
2. Kuo G, Choo QL, Alter HJ et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989: 244: 362.
3. Alter HJ. New kit on the block: evaluation of second-generation assays for detection of antibody to the hepatitis C virus. Hepatology 1992: 15: 350.
4. Pereira BJ, Milford EL, Kirkman RL, Levey AS. Transmission of hepatitis C virus by organ transplantation. N Engl J Med 1991: 325: 454.
5. Gomez E, Aguado S, Gago E et al.A study of renal transplants obtained from anti-HCV positive donors. Transplant Proc 1991: 23: 2654.
6. Roth D, Fernandez JA, Babischkin S et al. Detection of hepatitis C virus infection among cadaver organ donors: evidence for low transmission of disease. Ann Intern Med 1992: 117: 470.
7. Triolo G, Squiccimarro G, Baldi M et al. Antibodies to hepatitis C virus in kidney transplantation. Nephron 1992: 61: 276.
8. Mizrahi S, Hussey JL, Hayes DH, Boudreaux JP. Organ transplantation and hepatitis C virus infection. Lancet 1991: 337: 1100.
9. Diethelm AG, Roth D, Ferguson RM et al. Transmission of HCV by organ transplantation. N Engl J Med 1992: 326: 410, author reply 2-3.
10. Pirsch JD, Belzer FO. Transmission of HCV by organ transplantation. N Engl J Med 1992: 326: 412, author reply 3.
11. Pereira BJ, Wright TL, Schmid CH, Levey AS. A controlled study of hepatitis C transmission by organ transplantation. The New England Organ Bank Hepatitis C Study Group. Lancet 1995: 345: 484.
12. Bouthot BA, Murthy BV, Schmid CH, Levey AS, Pereira BJ. Long-term follow-up of hepatitis C virus infection among organ transplant recipients: implications for policies on organ procurement. Transplantation 1997: 63: 849.
13. Morales JM, Campistol JM, Castellano G et al. Transplantation of kidneys from donors with hepatitis C antibody into recipients with pre-transplantation anti-HCV. Kidney Int 1995: 47: 236.
14. Pirsch JD, Heisey D, D' Allesandro AM, Knechtle SJ, Sollinger HW, Belzer FO. Transplantation of hepatitis C (HCV) kidneys: defining the risks. 14th Annual Meeting of the American Society of Transplant Physicians, May 14-17, 1995, Chicago, IL.
15. Abbott KC, Bucci JR, Matsumoto CS et al. Hepatitis C and renal transplantation in the era of modern immunosuppression. J Am Soc Nephrol 2003: 14: 2908.
16. Abbott KC, Lentine KL, Bucci JR, Agodoa LY, Peters TG, Schnitzler MA. The impact of transplantation with deceased donor hepatitis C-positive kidneys on survival in wait-listed long-term dialysis patients. Am J Transplant 2004: 4: 2032.
17. Ali MK, Light JA, Barhyte DY et al. Donor hepatitis C virus status does not adversely affect short-term outcomes in HCV+ recipients in renal transplantation. Transplantation 1998: 66: 1694.
18. Kucirka LM, Singer AL, Ros RL, Montgomery RA, Dagher NN, Segev DL. Underutilization of hepatitis C-positive kidneys for hepatitis C-positive recipients. Am J Transplant 2010: 10: 1238.
19. Morales JM, Campistol JM, Dominguez-Gil B et al. Long-term experience with kidney transplantation from hepatitis C-positive donors into hepatitis C-positive recipients. Am J Transplant 2010: 10: 2453.
20. Pereira BJ, Wright TL, Schmid CH et al. Screening and confirmatory testing of cadaver organ donors for hepatitis C virus infection: a U.S. National Collaborative Study. Kidney Int 1994: 46: 886.
21. Bucci JR, Matsumoto CS, Swanson SJ et al. Donor hepatitis C seropositivity: clinical correlates and effect on early graft and patient survival in adult cadaveric kidney transplantation. J Am Soc Nephrol 2002: 13: 2974.
22. Schnitzler MA, Craig KE, Hardinger KE, Lowell JA, Brennan DC. Mycophenolate mofetil is associated with less death with function than azathioprine in cadaveric renal transplantation. Nephrol Dial Transplant 2003: 18: 1197.
23. Bucci JR, Lentine KL, Agodoa LY, Peters TG, Schnitzler MA, Abbott KC. Outcomes associated with recipient and donor hepatitis C serology status after kidney transplantation in the United States: analysis of the USRDS/UNOS database. Clin Transpl 2004: 51.
24. Bloom RD, Sayer G, Fa K, Constantinescu S, Abt P, Reddy KR. Outcome of hepatitis C virus-infected kidney transplant candidates who remain on the waiting list. Am J Transplant 2005: 5: 139.
25. Mandal AK, Kraus ES, Samaniego M et al. Shorter waiting times for hepatitis C virus seropositive recipients of cadaveric renal allografts from hepatitis C virus seropositive donors. Clin Transplant 2000: 14: 391.
26. Mathurin P, Mouquet C, Poynard T et al. Impact of hepatitis B and C virus on kidney transplantation outcome. Hepatology 1999: 29: 257.
27. Stock PG. Balancing multiple and conflicting allocation goals: a logical path forward. Am J Transplant 2009: 9: 1519.
28. Nampoory MR, Johny KV, Costandi JN et al. High incidence of proteinuria in hepatitis C virus-infected renal transplant recipients is associated with poor patient and graft outcome. Transplant Proc 2001: 33: 2791.
29. Gentil MA, Rocha JL, Rodriguez-Algarra G et al. Impaired kidney transplant survival in patients with antibodies to hepatitis C virus. Nephrol Dial Transplant 1999: 14: 2455.
30. Cosio FG, Roche Z, Agarwal A, Falkenhain ME, Sedmak DD, Ferguson RM. Prevalence of hepatitis C in patients with idiopathic glomerulopathies in native and transplant kidneys. Am J Kidney Dis 1996: 28: 752.
31. Cruzado JM, Carrera M, Torras J, Grinyo JM. Hepatitis C virus infection and de novo glomerular lesions in renal allografts. Am J Transplant 2001: 1: 171.
32. Brunkhorst R, Kliem V, Koch KM. Recurrence of membranoproliferative glomerulonephritis after renal transplantation in a patient with chronic hepatitis C. Nephron 1996: 72: 465.
33. Roccatello D, Fornasieri A, Giachino O et al. Multicenter study on hepatitis C virus-related cryoglobulinemic glomerulonephritis. Am J Kidney Dis 2007: 49: 69.
34. Roth D, Cirocco R, Zucker K et al. De novo membranoproliferative glomerulonephritis in hepatitis C virus-infected renal allograft recipients. Transplantation 1995: 59: 1676.
35. Hammoud H, Haem J, Laurent B et al. Glomerular disease during HCV infection in renal transplantation. Nephrol Dial Transplant 1996: 11(Suppl 4): 54.
36. Aroldi A, Lampertico P, Montagnino G et al. Natural history of hepatitis B and C in renal allograft recipients. Transplantation 2005: 79: 1132.
37. Hanafusa T, Ichikawa Y, Kishikawa H et al. Retrospective study on the impact of hepatitis C virus infection on kidney transplant patients over 20years. Transplantation 1998: 66: 471.
38. Zylberberg H, Nalpas B, Carnot F et al. Severe evolution of chronic hepatitis C in renal transplantation: a case control study. Nephrol Dial Transplant 2002: 17: 129.
39. Legendre C, Garrigue V, Le Bihan C et al. Harmful long-term impact of hepatitis C virus infection in kidney transplant recipients. Transplantation 1998: 65: 667.
40. Aroldi A, Lampertico P, Elli A et al. Long-term evolution of anti-HCV-positive renal transplant recipients. Transplant Proc 1998: 30: 2076.
41. National Kidney Foundation. KDIGO. Clinical practice guidelines for the prevention, diagnosis, evaluation, and treatment of hepatitis C in chronic kidney disease. Kidney Int 2008: 73: S1.